Non-small cell lung cancer

David S. Ettinger; Wallace Akerley; Gerold Bepler; Andrew Chang; Richard T. Cheney; Lucian R. Chirieac; Thomas A. D'Amico; Todd L. Demmy; Steven J. Feigenberg; Robert A. Figlin; Ramaswamy Govindan; Frederic W. Grannis; Thierry Jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Mark G. Kris; Corey J. Langer; Quynh Thu Le; Renato Martins; Gregory A. Otterson; Jyoti D. Patel; Francisco Robert; David J. Sugarbaker; Douglas E. Wood

doi:10.6004/jnccn.2008.0021

Non-small cell lung cancer

David S. Ettinger, Wallace Akerley, Gerold Bepler, Andrew Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Steven J. Feigenberg, Robert A. Figlin, Ramaswamy Govindan, Frederic W. Grannis, Thierry Jahan, Mohammad Jahanzeb, Anne Kessinger, Ritsuko Komaki, Mark G. Kris, Corey J. Langer, Quynh Thu Le, Renato MartinsGregory A. Otterson, Jyoti D. Patel, Francisco Robert, David J. Sugarbaker, Douglas E. Wood

Research output: Contribution to journal › Review article › peer-review

35 Scopus citations

Abstract

Lung cancer is the leading cause of cancer-related death in both men and women in the United States. An estimated 213,380 new cases (114,760 men and 98,620 women) of lung and bronchus cancer will be diagnosed in 2007, and 160,390 deaths (89,510 in men, 70,880 in women) are estimated to occur because of the disease. Non-small cell lung cancer (NSCLC) accounts for 80% to 85% of all lung cancer cases and includes 3 major types: (1) adenocarcinoma; (2) squamous cell (epidermoid) carcinoma; and (3) large-cell carcinoma. Adenocarcinoma is the most common type of lung cancer seen in the United States and is also the most frequently occurring cell type in nonsmokers. Important updates to the 2008 guidelines on NSCLC include the addition of tables on drugs and dosing information on chemotherapy regimens for adjuvant therapy.

Original language	English
Pages (from-to)	228-269
Number of pages	42
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	6
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2008.0021
State	Published - 2008

Keywords

Chemotherapy
Lung cancer
Multimodality therapy
NCCN Clinical Practice Guidelines
Non-small cell lung cancer
Radiation therapy
Targeted therapy
Thoracic surgery

Access to Document

10.6004/jnccn.2008.0021

Cite this

Ettinger, D. S., Akerley, W., Bepler, G., Chang, A., Cheney, R. T., Chirieac, L. R., D'Amico, T. A., Demmy, T. L., Feigenberg, S. J., Figlin, R. A., Govindan, R., Grannis, F. W., Jahan, T., Jahanzeb, M., Kessinger, A., Komaki, R., Kris, M. G., Langer, C. J., Le, Q. T., ... Wood, D. E. (2008). Non-small cell lung cancer. JNCCN Journal of the National Comprehensive Cancer Network, 6(3), 228-269. https://doi.org/10.6004/jnccn.2008.0021

@article{81124d6e58f340ec8096106854a905e6,

title = "Non-small cell lung cancer",

abstract = "Lung cancer is the leading cause of cancer-related death in both men and women in the United States. An estimated 213,380 new cases (114,760 men and 98,620 women) of lung and bronchus cancer will be diagnosed in 2007, and 160,390 deaths (89,510 in men, 70,880 in women) are estimated to occur because of the disease. Non-small cell lung cancer (NSCLC) accounts for 80% to 85% of all lung cancer cases and includes 3 major types: (1) adenocarcinoma; (2) squamous cell (epidermoid) carcinoma; and (3) large-cell carcinoma. Adenocarcinoma is the most common type of lung cancer seen in the United States and is also the most frequently occurring cell type in nonsmokers. Important updates to the 2008 guidelines on NSCLC include the addition of tables on drugs and dosing information on chemotherapy regimens for adjuvant therapy.",

keywords = "Chemotherapy, Lung cancer, Multimodality therapy, NCCN Clinical Practice Guidelines, Non-small cell lung cancer, Radiation therapy, Targeted therapy, Thoracic surgery",

author = "Ettinger, {David S.} and Wallace Akerley and Gerold Bepler and Andrew Chang and Cheney, {Richard T.} and Chirieac, {Lucian R.} and D'Amico, {Thomas A.} and Demmy, {Todd L.} and Feigenberg, {Steven J.} and Figlin, {Robert A.} and Ramaswamy Govindan and Grannis, {Frederic W.} and Thierry Jahan and Mohammad Jahanzeb and Anne Kessinger and Ritsuko Komaki and Kris, {Mark G.} and Langer, {Corey J.} and Le, {Quynh Thu} and Renato Martins and Otterson, {Gregory A.} and Patel, {Jyoti D.} and Francisco Robert and Sugarbaker, {David J.} and Wood, {Douglas E.}",

year = "2008",

doi = "10.6004/jnccn.2008.0021",

language = "English",

volume = "6",

pages = "228--269",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "3",

}

Ettinger, DS, Akerley, W, Bepler, G, Chang, A, Cheney, RT, Chirieac, LR, D'Amico, TA, Demmy, TL, Feigenberg, SJ, Figlin, RA, Govindan, R, Grannis, FW, Jahan, T, Jahanzeb, M, Kessinger, A, Komaki, R, Kris, MG, Langer, CJ, Le, QT, Martins, R, Otterson, GA, Patel, JD, Robert, F, Sugarbaker, DJ & Wood, DE 2008, 'Non-small cell lung cancer', JNCCN Journal of the National Comprehensive Cancer Network, vol. 6, no. 3, pp. 228-269. https://doi.org/10.6004/jnccn.2008.0021

TY - JOUR

T1 - Non-small cell lung cancer

AU - Ettinger, David S.

AU - Akerley, Wallace

AU - Bepler, Gerold

AU - Chang, Andrew

AU - Cheney, Richard T.

AU - Chirieac, Lucian R.

AU - D'Amico, Thomas A.

AU - Demmy, Todd L.

AU - Feigenberg, Steven J.

AU - Figlin, Robert A.

AU - Govindan, Ramaswamy

AU - Grannis, Frederic W.

AU - Jahan, Thierry

AU - Jahanzeb, Mohammad

AU - Kessinger, Anne

AU - Komaki, Ritsuko

AU - Kris, Mark G.

AU - Langer, Corey J.

AU - Le, Quynh Thu

AU - Martins, Renato

AU - Otterson, Gregory A.

AU - Patel, Jyoti D.

AU - Robert, Francisco

AU - Sugarbaker, David J.

AU - Wood, Douglas E.

PY - 2008

Y1 - 2008

N2 - Lung cancer is the leading cause of cancer-related death in both men and women in the United States. An estimated 213,380 new cases (114,760 men and 98,620 women) of lung and bronchus cancer will be diagnosed in 2007, and 160,390 deaths (89,510 in men, 70,880 in women) are estimated to occur because of the disease. Non-small cell lung cancer (NSCLC) accounts for 80% to 85% of all lung cancer cases and includes 3 major types: (1) adenocarcinoma; (2) squamous cell (epidermoid) carcinoma; and (3) large-cell carcinoma. Adenocarcinoma is the most common type of lung cancer seen in the United States and is also the most frequently occurring cell type in nonsmokers. Important updates to the 2008 guidelines on NSCLC include the addition of tables on drugs and dosing information on chemotherapy regimens for adjuvant therapy.

AB - Lung cancer is the leading cause of cancer-related death in both men and women in the United States. An estimated 213,380 new cases (114,760 men and 98,620 women) of lung and bronchus cancer will be diagnosed in 2007, and 160,390 deaths (89,510 in men, 70,880 in women) are estimated to occur because of the disease. Non-small cell lung cancer (NSCLC) accounts for 80% to 85% of all lung cancer cases and includes 3 major types: (1) adenocarcinoma; (2) squamous cell (epidermoid) carcinoma; and (3) large-cell carcinoma. Adenocarcinoma is the most common type of lung cancer seen in the United States and is also the most frequently occurring cell type in nonsmokers. Important updates to the 2008 guidelines on NSCLC include the addition of tables on drugs and dosing information on chemotherapy regimens for adjuvant therapy.

KW - Chemotherapy

KW - Lung cancer

KW - Multimodality therapy

KW - NCCN Clinical Practice Guidelines

KW - Non-small cell lung cancer

KW - Radiation therapy

KW - Targeted therapy

KW - Thoracic surgery

UR - http://www.scopus.com/inward/record.url?scp=41749109328&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2008.0021

DO - 10.6004/jnccn.2008.0021

M3 - Review article

C2 - 18377844

AN - SCOPUS:41749109328

SN - 1540-1405

VL - 6

SP - 228

EP - 269

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Non-small cell lung cancer

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this